Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Renewed Political Pressure on Hydroxychloroquine for COVID Highlights Need For Independent US FDA

08 Jul 2020

• By Sarah Karlin-Smith

Highway Signpost with Political Pressure wording on Sky Background. — President Trump and a top White House adviser thrust Commissioner Stephen Hahn into a tricky spot this week by once again endorsing hydroxychloroquine for COVID-19 • Source: Shutterstock

Related Content

An Independent US FDA: Gottlieb Supports Position, But Is Pessimistic About Prospects

21 May 2019

Coronavirus Notebook: New Nordic Studies, Vaccine Solidarity Pledges, And The Re-Start Of COPCOV

02 Jul 2020

Hydroxychloroquine EUA Is First Rx Victim Of Hahn’s ‘Move Fast, Course Correct’ Philosophy

16 Jun 2020

Panel Of Former US FDA Commissioners Make Renewed Call For Independent Agency

26 Oct 2018

FDA's Emergency Use Authorization for Malaria Drugs Could Hinder Trials of Other COVID-19 Treatments

31 Mar 2020

Additional Topics

United States Coronavirus COVID-19 Leadership Politics FDA Real-World Evidence Infectious Diseases BioPharmaceutical

More from Agency Leadership

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.